291 related articles for article (PubMed ID: 34471099)
1. A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response.
Zhao Y; Sui L; Wu P; Wang W; Wang Z; Yu Y; Hou Z; Tan G; Liu Q; Wang G
Signal Transduct Target Ther; 2021 Sep; 6(1):331. PubMed ID: 34471099
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452305
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Oh SJ; Shin OS
Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
[TBL] [Abstract][Full Text] [Related]
6. The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
Hu Y; Li W; Gao T; Cui Y; Jin Y; Li P; Ma Q; Liu X; Cao C
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148787
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production.
Chen K; Xiao F; Hu D; Ge W; Tian M; Wang W; Pan P; Wu K; Wu J
Viruses; 2020 Dec; 13(1):. PubMed ID: 33396605
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-β Production by Inducing Ubiquitination of RIG-I.
Liu Y; Liang QZ; Lu W; Yang YL; Chen R; Huang YW; Wang B
Front Immunol; 2021; 12():688758. PubMed ID: 34220846
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
11. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
Yamada T; Sato S; Sotoyama Y; Orba Y; Sawa H; Yamauchi H; Sasaki M; Takaoka A
Nat Immunol; 2021 Jul; 22(7):820-828. PubMed ID: 33976430
[TBL] [Abstract][Full Text] [Related]
12. Evasion of Type I Interferon by SARS-CoV-2.
Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
[TBL] [Abstract][Full Text] [Related]
13. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
Smits VAJ; Hernández-Carralero E; Paz-Cabrera MC; Cabrera E; Hernández-Reyes Y; Hernández-Fernaud JR; Gillespie DA; Salido E; Hernández-Porto M; Freire R
Biochem Biophys Res Commun; 2021 Mar; 543():45-49. PubMed ID: 33515911
[TBL] [Abstract][Full Text] [Related]
14. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
[TBL] [Abstract][Full Text] [Related]
16. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
Front Immunol; 2021; 12():664619. PubMed ID: 34305895
[TBL] [Abstract][Full Text] [Related]
17. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.
Kehrer T; García-Sastre A; Miorin L
J Interferon Cytokine Res; 2021 Jun; 41(6):205-219. PubMed ID: 34161170
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.
Xia H; Shi PY
J Interferon Cytokine Res; 2020 Dec; 40(12):543-548. PubMed ID: 33337934
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3.
Freitas RS; Crum TF; Parvatiyar K
Front Cell Infect Microbiol; 2021; 11():789462. PubMed ID: 35083167
[TBL] [Abstract][Full Text] [Related]
20. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
